Reports for AA PHARMA INC
Company Name AA PHARMA INC |
||
|---|---|---|
Totals |
||
Shortage reports |
446 |
|
| Actual shortage: | 21 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (1%) | |
| Resolved: | 419 (94%) | |
Discontinuation Reports |
63 |
|
| To be discontinued: | 9 (14%) | |
| Discontinued: | 52 (83%) | |
| Reversed: | 2 (3%) | |
Late reports |
30 (6%) |
|
Overdue reports |
20 (67%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2024-10-18 | 2024-12-11 | 240624 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2025-02-06 | 2025-03-19 | 249651 |
| MEFLOQUINE | 250MG | TABLET | Resolved | 2023-08-23 | 2023-09-14 | 202753 |
| MEGESTROL | 160MG | TABLET | Resolved | 2024-05-24 | 2025-04-04 | 228783 |
| MEGESTROL | 40MG | TABLET | Resolved | 2020-07-07 | 2020-07-24 | 119624 |
| MEGESTROL | 40MG | TABLET | Resolved | 2022-11-22 | 2022-11-29 | 175461 |
| MEGESTROL | 40MG | TABLET | Resolved | 2023-03-30 | 2023-08-23 | 188323 |
| MEGESTROL | 40MG | TABLET | Resolved | 2024-06-12 | 2025-04-04 | 230221 |
| METHAZOLAMIDE | 50 MG | Tablet | Resolved | 2017-03-13 | 2017-05-30 | 2010 |
| METHAZOLAMIDE | 50MG | TABLET | Resolved | 2017-05-30 | 2017-06-03 | 11570 |
| METHAZOLAMIDE | 50MG | TABLET | Resolved | 2021-08-10 | 2021-09-30 | 143933 |
| METHAZOLAMIDE | 50MG | TABLET | Resolved | 2022-02-02 | 2022-04-01 | 154065 |
| METHAZOLAMIDE | 50MG | TABLET | Resolved | 2022-07-22 | 2022-09-30 | 165274 |
| METHAZOLAMIDE | 50MG | TABLET | Resolved | 2023-06-29 | 2023-08-03 | 196840 |
| METHAZOLAMIDE | 50MG | TABLET | Resolved | 2024-03-11 | 2024-11-07 | 221860 |
| METHAZOLAMIDE | 50MG | TABLET | Actual shortage | 2024-12-19 | 2025-03-19 | 245994 |
| METHOPRAZINE | 2MG | TABLET | Resolved | 2019-01-10 | 2019-02-09 | 71861 |
| METHOPRAZINE | 2MG | TABLET | Resolved | 2023-02-08 | 2023-03-16 | 183864 |
| METHOPRAZINE | 5MG | TABLET | Resolved | 2022-05-27 | 2023-03-16 | 161409 |
| METHOPRAZINE | 5MG | TABLET | Resolved | 2025-01-13 | 2025-03-12 | 247522 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PHENYTOIN SODIUM | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-12-28 | 60687 |
| AVENTYL | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2022-01-27 | 65435 |
| CHLORAX | 2.5MG 5MG | CAPSULE | Discontinued | 2022-01-20 | 2022-01-21 | 153244 |
| CHLORDIAZEPOXIDE | 10MG | CAPSULE | Discontinued | 2024-06-26 | 2024-06-27 | 231340 |
| CHLORDIAZEPOXIDE | 5MG | CAPSULE | Discontinued | 2024-06-26 | 2024-06-27 | 231343 |
| CHLORDIAZEPOXIDE | 25MG | CAPSULE | To be discontinued | 2024-06-26 | 2024-06-26 | 231348 |
| DIFLUNISAL | 250MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108364 |
| DIFLUNISAL | 500MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108367 |
| DOXEPIN | 50MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65463 |
| ELAVIL | 50MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247839 |
| ELAVIL | 50MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247836 |
| ELAVIL | 25MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247833 |
| ELAVIL | 25MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247830 |
| ELAVIL | 10MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247827 |
| ELAVIL | 10MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247824 |
| ELAVIL | 75MG | TABLET | To be discontinued | 2025-01-16 | 2025-01-16 | 247842 |
| ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2022-04-01 | 2022-04-02 | 157808 |
| ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2017-03-28 | 2017-03-28 | 4584 |
| ERYTHRO-ES | Discontinued | 2018-12-07 | 2018-12-08 | 68904 | ||
| ERYTHRO-ES | 600MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121825 |